The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
The ever-increasing burden of type 2 diabetes mellitus (T2DM) worldwide, has led to the emergence of several antidiabetes drugs with different modes of action. Incretin hormones and their effect on glucose metabolism and pathogenesis of T2DM has been a landmark discovery in the management of this in...
Enregistré dans:
Auteur principal: | Juris J. Meier |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3f80af6f0ce043bc92ebdb42b6a1472a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
par: Ekaterina Alekseevna Shestakova
Publié: (2011) -
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
par: Enrique Z. Fisman, et autres
Publié: (2021) -
Incretin-based therapy: renal effects
par: Anton Ivanovich Korbut, et autres
Publié: (2016) -
Incretins today: multiple effects and therapeutic potential
par: Oksana V. Tsygankova, et autres
Publié: (2019) -
Vildagliptin: optimal control in type 2 diabetes mellitus treatment
par: Alexander Sergeevich Ametov
Publié: (2015)